GW Henssler & Associates Ltd. reduced its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 16.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 102,815 shares of the technology company’s stock after selling 20,036 shares during the period. GW Henssler & Associates Ltd. owned 0.10% of Amdocs worth $8,278,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. WealthCollab LLC increased its stake in Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after purchasing an additional 173 shares during the last quarter. Atlantic Union Bankshares Corp purchased a new position in Amdocs in the third quarter valued at approximately $37,000. BOK Financial Private Wealth Inc. purchased a new position in Amdocs in the fourth quarter valued at approximately $37,000. Abich Financial Wealth Management LLC purchased a new position in shares of Amdocs during the third quarter worth approximately $39,000. Finally, Advisory Services Network LLC purchased a new position in shares of Amdocs during the third quarter worth approximately $42,000. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Amdocs Stock Performance
NASDAQ:DOX opened at $65.26 on Tuesday. The firm’s fifty day moving average price is $64.26 and its 200 day moving average price is $71.80. Amdocs Limited has a 1-year low of $59.40 and a 1-year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98. The firm has a market cap of $7.04 billion, a price-to-earnings ratio of 13.05, a price-to-earnings-growth ratio of 0.97 and a beta of 0.38.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is 45.60%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on DOX. Cfra lowered shares of Amdocs to a “sell” rating in a research report on Thursday, May 14th. Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Stifel Nicolaus lowered their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Finally, Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Amdocs currently has an average rating of “Hold” and a consensus price target of $86.67.
Check Out Our Latest Research Report on Amdocs
Amdocs Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
